Resisting RECIST-Uniformity Versus Clinical Validity.
Identifieur interne : 004A99 ( Ncbi/Curation ); précédent : 004A98; suivant : 004B00Resisting RECIST-Uniformity Versus Clinical Validity.
Auteurs : Michelle K. Wilson [Canada] ; Michael L. Friedlander ; Stephanie Lheureux ; William Small ; Andrés Poveda ; Eric Pujade-Lauraine ; Katherine Karakasis ; Monica Bacon ; Valerie Bowering ; Tanya Chawla ; Amit M. OzaSource :
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2017.
Abstract
The Response Evaluation Criteria in Solid Tumors (RECIST) International Working Group developed criteria for tumor response and progression to standardize radiological assessment in patients receiving chemotherapy in phase 2 trials. However, it is unclear whether the defined percentage change in tumor size and volume reflects true clinical benefit for the patient. The RECIST criteria were designed to improve objectivity in trials, but not to replace clinical decision making. The aim of this study was to understand clinicians' opinions about RECIST in current oncology practice.
DOI: 10.1097/IGC.0000000000001062
PubMed: 28692635
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000306
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000304
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000304
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :004A99
Links to Exploration step
pubmed:28692635Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Resisting RECIST-Uniformity Versus Clinical Validity.</title><author><name sortKey="Wilson, Michelle K" sort="Wilson, Michelle K" uniqKey="Wilson M" first="Michelle K" last="Wilson">Michelle K. Wilson</name><affiliation wicri:level="1"><nlm:affiliation>*Auckland City Hospital, Auckland, New Zealand; †Prince of Wales Hospital, Sydney, Australia; ‡Princess Margaret Cancer Centre, Toronto, Ontario Canada; §Department of Radiation Oncology, Loyol University, Chicago, IL; ‖Instituto Valenciano de Oncologia, Valencia, Spain; ¶Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Paris, France; and #Gynecologic Group Intergroup, Kingston, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>*Auckland City Hospital, Auckland, New Zealand; †Prince of Wales Hospital, Sydney, Australia; ‡Princess Margaret Cancer Centre, Toronto, Ontario Canada; §Department of Radiation Oncology, Loyol University, Chicago, IL; ‖Instituto Valenciano de Oncologia, Valencia, Spain; ¶Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Paris, France; and #Gynecologic Group Intergroup, Kingston</wicri:regionArea><wicri:noRegion>Kingston</wicri:noRegion></affiliation></author><author><name sortKey="Friedlander, Michael L" sort="Friedlander, Michael L" uniqKey="Friedlander M" first="Michael L" last="Friedlander">Michael L. Friedlander</name></author><author><name sortKey="Lheureux, Stephanie" sort="Lheureux, Stephanie" uniqKey="Lheureux S" first="Stephanie" last="Lheureux">Stephanie Lheureux</name></author><author><name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name></author><author><name sortKey="Poveda, Andres" sort="Poveda, Andres" uniqKey="Poveda A" first="Andrés" last="Poveda">Andrés Poveda</name></author><author><name sortKey="Pujade Lauraine, Eric" sort="Pujade Lauraine, Eric" uniqKey="Pujade Lauraine E" first="Eric" last="Pujade-Lauraine">Eric Pujade-Lauraine</name></author><author><name sortKey="Karakasis, Katherine" sort="Karakasis, Katherine" uniqKey="Karakasis K" first="Katherine" last="Karakasis">Katherine Karakasis</name></author><author><name sortKey="Bacon, Monica" sort="Bacon, Monica" uniqKey="Bacon M" first="Monica" last="Bacon">Monica Bacon</name></author><author><name sortKey="Bowering, Valerie" sort="Bowering, Valerie" uniqKey="Bowering V" first="Valerie" last="Bowering">Valerie Bowering</name></author><author><name sortKey="Chawla, Tanya" sort="Chawla, Tanya" uniqKey="Chawla T" first="Tanya" last="Chawla">Tanya Chawla</name></author><author><name sortKey="Oza, Amit M" sort="Oza, Amit M" uniqKey="Oza A" first="Amit M" last="Oza">Amit M. Oza</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28692635</idno><idno type="pmid">28692635</idno><idno type="doi">10.1097/IGC.0000000000001062</idno><idno type="wicri:Area/PubMed/Corpus">000306</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000306</idno><idno type="wicri:Area/PubMed/Curation">000304</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000304</idno><idno type="wicri:Area/PubMed/Checkpoint">000304</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000304</idno><idno type="wicri:Area/Ncbi/Merge">004A99</idno><idno type="wicri:Area/Ncbi/Curation">004A99</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Resisting RECIST-Uniformity Versus Clinical Validity.</title><author><name sortKey="Wilson, Michelle K" sort="Wilson, Michelle K" uniqKey="Wilson M" first="Michelle K" last="Wilson">Michelle K. Wilson</name><affiliation wicri:level="1"><nlm:affiliation>*Auckland City Hospital, Auckland, New Zealand; †Prince of Wales Hospital, Sydney, Australia; ‡Princess Margaret Cancer Centre, Toronto, Ontario Canada; §Department of Radiation Oncology, Loyol University, Chicago, IL; ‖Instituto Valenciano de Oncologia, Valencia, Spain; ¶Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Paris, France; and #Gynecologic Group Intergroup, Kingston, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>*Auckland City Hospital, Auckland, New Zealand; †Prince of Wales Hospital, Sydney, Australia; ‡Princess Margaret Cancer Centre, Toronto, Ontario Canada; §Department of Radiation Oncology, Loyol University, Chicago, IL; ‖Instituto Valenciano de Oncologia, Valencia, Spain; ¶Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Paris, France; and #Gynecologic Group Intergroup, Kingston</wicri:regionArea><wicri:noRegion>Kingston</wicri:noRegion></affiliation></author><author><name sortKey="Friedlander, Michael L" sort="Friedlander, Michael L" uniqKey="Friedlander M" first="Michael L" last="Friedlander">Michael L. Friedlander</name></author><author><name sortKey="Lheureux, Stephanie" sort="Lheureux, Stephanie" uniqKey="Lheureux S" first="Stephanie" last="Lheureux">Stephanie Lheureux</name></author><author><name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name></author><author><name sortKey="Poveda, Andres" sort="Poveda, Andres" uniqKey="Poveda A" first="Andrés" last="Poveda">Andrés Poveda</name></author><author><name sortKey="Pujade Lauraine, Eric" sort="Pujade Lauraine, Eric" uniqKey="Pujade Lauraine E" first="Eric" last="Pujade-Lauraine">Eric Pujade-Lauraine</name></author><author><name sortKey="Karakasis, Katherine" sort="Karakasis, Katherine" uniqKey="Karakasis K" first="Katherine" last="Karakasis">Katherine Karakasis</name></author><author><name sortKey="Bacon, Monica" sort="Bacon, Monica" uniqKey="Bacon M" first="Monica" last="Bacon">Monica Bacon</name></author><author><name sortKey="Bowering, Valerie" sort="Bowering, Valerie" uniqKey="Bowering V" first="Valerie" last="Bowering">Valerie Bowering</name></author><author><name sortKey="Chawla, Tanya" sort="Chawla, Tanya" uniqKey="Chawla T" first="Tanya" last="Chawla">Tanya Chawla</name></author><author><name sortKey="Oza, Amit M" sort="Oza, Amit M" uniqKey="Oza A" first="Amit M" last="Oza">Amit M. Oza</name></author></analytic><series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title><idno type="eISSN">1525-1438</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The Response Evaluation Criteria in Solid Tumors (RECIST) International Working Group developed criteria for tumor response and progression to standardize radiological assessment in patients receiving chemotherapy in phase 2 trials. However, it is unclear whether the defined percentage change in tumor size and volume reflects true clinical benefit for the patient. The RECIST criteria were designed to improve objectivity in trials, but not to replace clinical decision making. The aim of this study was to understand clinicians' opinions about RECIST in current oncology practice.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A99 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 004A99 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:28692635
|texte= Resisting RECIST-Uniformity Versus Clinical Validity.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:28692635" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |